• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number SE-05-150-120-6F
Device Problem Break (1069)
Patient Problems Neurological Deficit/Dysfunction (1982); Stenosis (2263); Claudication (2550); Diminished Pulse Pressure (2606)
Event Date 07/02/2019
Event Type  Injury  
Manufacturer Narrative
Date of event - estimate.Exemption number (b)(4).The stent remains in the patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was performed to treat an occlusion in the popliteal artery to infrapatellar segment.On (b)(6) 2019, a 5x150mm supera self-expanding stent was deployed.On (b)(6) 2019, the patient was re-hospitalized due to lameness.An angiogram was performed and restenosis was confirmed.A possible fracture to the stent was noted.A 6x150mm non-abbott balloon catheter was used to successfully treat the patient.No additional information was provided.
 
Manufacturer Narrative
Exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents and/or complaints from this lot.The reported patient effects of restenosis and claudication are listed in the supera instructions for use as known potential patient effects associated with the use of the device.The investigation was unable to determine a cause for the reported stent fracture.It may be possible that the supera stent was subjected to stress/fatigue or repetitive movement due to anatomical conditions and location of the implant; however, this could not be confirmed.The additional patient effects and treatments including hospitalization are due to case circumstances.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.Code 1982 was removed.
 
Event Description
Additional information was received: the patient was re-hospitalized on (b)(6) 2019 due to insufficient arterial circulation in lower limb and pain in leg when walking.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA PERIPHERAL STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key8967348
MDR Text Key156748935
Report Number2024168-2019-11508
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 12/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/05/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2019
Device Catalogue NumberSE-05-150-120-6F
Device Lot Number8010361
Was Device Available for Evaluation? No
Date Manufacturer Received11/18/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age68 YR
Patient Weight60
-
-